Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Abstract Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute myocardial infarction (STEMI) has no biological inclusion criteria. Here, we analyzed 63 biomarkers and cytokines in baseline plasma samples from 77 STEMI patients treated with BM-MNCs in the TIME and Late-TIME trials as we...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/47663ea787eb4f74b71588c098542657 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|